证券记录 · 已归档季度
ELAN
Elanco Animal Health Incorporated · Healthcare · Drug Manufacturers - Specialty & Generic
20被追踪持有人
-1Δ持有人
348.71M持有股份
$7.02B报告持仓市值
+0新建仓位
−2清仓
动量输入（同类管理人）：
持有人广度 -4.8% ·
股份流向 +6.4% ·
净新建仓位 -10.0%
· 公式
集中增持：持股数量上升，持有人数量减少
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 4 | 0 | 276.62K | $5.90M | n/a | n/a |
| Q2 2026 | 130 | +5 | 426.69M | $10.50B | +12 | −6 |
| Q1 2026 | 127 | -2 | 403.59M | $9.65B | +6 | −9 |
| Q4 2025 | 128 | +1 | 433.50M | $9.81B | +4 | −2 |
| Q3 2025 | 20 | -1 | 348.71M | $7.02B | n/a | −2 |
| Q2 2025 | 19 | +2 | 313.01M | $4.47B | +3 | −1 |
| Q1 2025 | 14 | -2 | 167.03M | $1.75B | +1 | −3 |
| Q4 2024 | 16 | -2 | 168.00M | $2.03B | n/a | −2 |
| Q3 2024 | 17 | +1 | 175.40M | $2.58B | +1 | n/a |
| Q2 2024 | 16 | n/a | 207.32M | $2.99B | n/a | n/a |
持有人 · Q3 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Dodge & Cox ✦ | 82.76M | -0.2% | $1.67B | 0.9% | ▼ Trim | 6 | SEC ↗ |
| 2 | Fidelity (FMR) ✦ | 65.36M | +0.7% | $1.32B | 0.1% | ▲ Add | 2 | SEC ↗ ×5 |
| 3 | PRIMECAP Management ✦ | 49.96M | -3.5% | $1.01B | 0.8% | ▼ Trim | 6 | SEC ↗ |
| 4 | The Vanguard Group ✦ (被动) | 48.59M | +1.6% | $978.54M | 0.0% | ▲ Add | 2 | SEC ↗ ×5 |
| 5 | BlackRock ✦ (被动) | 46.18M | +100.2% | $930.04M | 0.0% | ▲ Add | 2 | SEC ↗ ×18 |
| 6 | State Street Global Advisors ✦ (被动) | 15.25M | +67.0% | $307.05M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 7 | Morgan Stanley ✦ | 10.27M | n/a | $206.76M | 0.0% | n/c | 1 | SEC ↗ ×9 |
| 8 | Geode Capital Management ✦ (被动) | 8.79M | +8.9% | $176.97M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 9 | Millennium Management ✦ | 5.61M | +46.3% | $113.04M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 10 | Citadel Advisors ✦ | 4.84M | -64.7% | $97.55M | 0.1% | ▼ Trim | 6 | SEC ↗ ×2 |
| 11 | JPMorgan Chase ✦ | 3.84M | n/a | $77.27M | 0.0% | n/c | 1 | SEC ↗ ×14 |
| 12 | Capital World Investors ✦ | 2.08M | +3.9% | $41.87M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 13 | Goldman Sachs Group ✦ | 1.38M | n/a | $27.82M | 0.0% | n/c | 1 | SEC ↗ ×4 |
| 14 | Wellington Management ✦ | 1.28M | -9.4% | $25.88M | 0.0% | ▼ Trim | 6 | SEC ↗ ×3 |
| 15 | Point72 Asset Management ✦ | 1.26M | -36.0% | $25.38M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 16 | T. Rowe Price ✦ | 418.30K | +5.8% | $8.43M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 17 | Marshall Wace ✦ | 367.34K | +3.4% | $7.40M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 18 | D. E. Shaw & Co. ✦ | 189.40K | -11.9% | $3.81M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 19 | AQR Capital Management ✦ | 190.62K | +14.1% | $3.74M | 0.0% | ▲ Add | 6 | SEC ↗ ×4 |
| 20 | Gotham Asset Management ✦ | 111.90K | -10.5% | $2.25M | 0.0% | ▼ Trim | 6 | SEC ↗ |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| Norges Bank | $12.50M | 曾为 0.0% |
| Arrowstreet Capital | $4.43M | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 512 持有人, 543.55M 股份, $11.98B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
公开市场买入 (P)
Aug 20
Kurzius Lawrence Erik
Director · 40.00K 股 @ 23.40 · $935,920
Aug 18
O'Neill Shiv
Officer · GC AND CORP SEC · 4.00K 股 @ 23.58 · $94,273
Aug 12
Harrington Michael J
Director · 5.00K 股 @ 21.82 · $109,100
Aug 07
Herendeen Paul
Director · 10.00K 股 @ 23.68 · $236,850
Aug 07
VanHimbergen Robert M
Officer · EVP and CFO · 4.20K 股 @ 23.08 · $96,926
公开市场卖出 (S)
Oct 15
Bettington Timothy J
Officer · 4.35K 股 · $100,050
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
Jul 14
SC 13G: DIMENSIONAL FUND ADVISORS LP
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2025 ·
方法论 ·
通过API获取此数据